Research Article
Work Ability and Employment in Rheumatoid Arthritis: A Cross-Sectional Study on the Role of Muscle Strength and Lower Extremity Function
Table 1
Characteristics of the study population and univariate comparison of subjects with and without gainful employment.
| | Total population(n=100) | Gainfully employed subjects(n=59) | Non-gainfully employed subject (n=41) | p-value | Variable | N | Mean (SD)/Median [IQR] | | N | Mean (SD)/Median [IQR] | | N | Mean(SD)/Median[IQR] | | |
| Female gender | 66 | | 66 | 38 | | 64 | 28 | | 68.3 | 0.830 | Age – years | | 53.0 | | | 49.0 | | | 58.0 | | <0.001 | In a relationship | 71 | | 71 | 44 | | 75 | 27 | | 66 | 0.340 | Education level | | | | | | | | | | 0.013 | Compulsory | 18 | | 18 | 5 | | 8 | 13 | | 34 | | Secondary | 71 | | 71 | 46 | | 78 | 25 | | 61 | | Higher | 11 | | 11 | 8 | | 14 | 3 | | 7 | | Disease duration – months | | 78.00 | | | 60.0 | | | 78.0 (36.5-192) | | 0.260 | Disease activity – CDAI | | 8.0 (8.2) | | | 0.8 (7.9) | | | 8.4 (8.8) | | 0.644 | Pain - VAS | | 3.5 (2.05) | | | 3.3 (1.9) | | | 4.1 (2.2) | | 0.056 | Inflammatory marker | | | | | | | | | | | CRP - mg/dl | | 3.2 | | | 2.6 | | | 3.9 | | 0.035 | IL-6 - pg/ml | | 3.9 | | | 3.7 | | | 4.1 | | 0.443 | TNF-alpha - µg/ml | | 1.6 | | | 1.3 | | | 1.9 | | 0.273 | Rheumatoid arthritis medication | | | | | | | | | | | sDMARDs | 80 | | 80 | 46 | | 78 | 34 | | 83 | 0.617 | bDMARDs | 44 | | 44 | 30 | | 50.8 | 14 | | 34.1 | 0.107 | Corticosteroids | 17 | | 17 | 10 | | 16.9 | 7 | | 17 | 1.000 | NSAIDs/Pain killers | 15 | | 15 | 9 | | 15.3 | 6 | | 14.6 | 1.000 | Comedication (non-RA) | 55 | | 55 | 25 | | 42.4 | 30 | | 73.2 | 0.001 | Number of comedication | | 1 | | | 0 | | | 2 | | 0.002 | Comorbidities | | | | | | | | | | | Presence of comorbidity | 65 | | 65 | 32 | | 54 | 33 | | 81 | 0.007 | Number of comorbidities | | 1 | | | 1 | | | 2.0 | | 0.005 | Functional Disability (HAQ - DI) | | 0.5 | | | 0.4 | | | 0.8 | | 0.009 | HAQ-DI ≤ 1, no disability | 70 | | 70 | 50 | | | 27 | | | 0.067 | HAQ-DI >1, disability | 28 | | 28 | 9 | | | 12 | | | | Job demands | | | | | | | | | | | Predominantly physical | 10 | | 17 | | | | | | | | Predominantly mental | 21 | | 36 | | | | | | | | Mixed physical and mental | 28 | | 47 | | | | | | | | Workability index single item (WAS) | | 7.00 | | | 8.0 | | | 4 | | <0.001 | Workability index (WAI) | | 37.3 | | | | | | | | | Muscle strength - kg | | | | | | | | | | | Hand grip strength | | 29.4 (14.4) | | | 32.1(14.9) | | | 25.5 (12.9) | | 0.024 | Knee extensor strength | | 36.4 (16.8) | | | 41.5(17.1) | | | 29.2 (13.6) | | <0.001 | Lower extremity function - (SPPB) total | | 10.8 (1.9) | | | 11.3 (1.5) | | | 10.1 (2.2) | | 0.003 | Chair stands | | 3.2 (1.2) | | | 3.6 (0.9) | | | 2.7 (1.3) | | 0.010 | Balance test | | 3.7 (0.7) | | | 3.8 (0.6) | | | 3.6 (0.9) | | 0.262 | Walking test | | 3.9 (0.5) | | | 3.9 (0.3) | | | 3.8 (0.7) | | 0.030 |
|
|
SD=standard deviation, IQR=interquartile range, CDAI=clinical disease activity index, VAS=visual analogue scale, CRP=C-reactive protein, IL-6=interleukin-6, TNF-alpha=tumor necrosis factor-alpha, s/b DMARD=synthetic/biological disease-modifying antirheumatic drug, WAI=workability index, WAS=single item workability index, SPPB=short physical performance battery, and HAQ-DI=health assessment questionnaire-disability index. Assessed for gainfully employed patients only. |